Compared to earlier Phase III study, women’s adherence to monthly HIV prevention ring is higher and data suggest infection rates are lower.
New Prevention Technologies
First clinical trial of IPM’s dual-purpose vaginal ring builds on promising microbicide technology to address overlapping threats to women’s sexual and reproductive health
Related Content:
Civil Society Roundtable with Dr. Zeda Rosenberg, CEO, International Partnership for Microbicides (IPM) - 27 February February 21, 2019 Please join the Interagency Coalition on AIDS and Development (ICAD) and the International Partnership for Microbicides (IPM) for a brown bag lunch and roundtable discussion featuring Dr. Zeda Rosenberg, CEO,…
Statement: European Medicine’s Agency Positive Opinion on Dapivirine Ring is a Turning Point towards Women-centred HIV Prevention July 24, 2020 FOR IMMEDIATE RELEASE 24 July 2020 (Ottawa, ON) – ICAD congratulates the International Partnership on Microbicides (IPM) on its announcement today that the European Medicine’s Agency (EMA) has issued a…
Closing the Gap? Cut the Crap! December 4, 2018 New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention OptionsBy Marc-André LeBlanc, Founding member of IRMA International Rectal Microbicide Advocates (IRMA) and our many partners and…- ICAD Applauds Canada For its Renewed Commitment and Global Leadership Ushering in a Bold New Era Where Gender Equality is at the Centre of its Global Health Agenda June 4, 2019 ICAD Applauds Canada For its Renewed Commitment and Global Leadership Ushering in a Bold New Era Where Gender Equality is at the Centre of its Global Health Agenda For immediate…
- Bridging the Gap Between Community and Researchers December 4, 2018 By Jes Hovanes, Communications and Social Media Officer, CIHR Canadian HIV Trials NetworkThere is a line in Tony Kushner’s 1991 play Angels in America where, in the early days of…
- Canada’s hidden HIV epidemic December 7, 2018 By Laurie Edmiston, CATIEEarlier this year, I witnessed a profound historic moment at the International AIDS Conference in Amsterdam. Dr. Alison Rodger, a leading HIV researcher in the United Kingdom,…